Article Details

NGM Biopharmaceuticals (NASDAQ:NGM) Price Target Raised to $42.00 at Raymond James

Retrieved on: 2021-11-06 15:10:50

Tags for this article:

Click the tags to see associated articles and topics

NGM Biopharmaceuticals (NASDAQ:NGM) Price Target Raised to $42.00 at Raymond James. View article details on hiswai:

Excerpt

Raymond James raised their target price on NGM Biopharmaceuticals from $39.00 to $42.00 and gave the company a "strong-buy" rating in a research ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up